Labopharm inks $170M distribution deal with Purdue Pharma

Labopharm tapped Purdue Pharma today as US licensee and distributor for the analgesic tramadol. Labopharm expects to submit its new drug application for tramadol to the FDA later this year. The licensing deal nets Labopharm an upfront fee of $20 million plus $40 million on FDA approval; the total cash payments could reach $170 million, plus royalties of 20 percent to 25 percent.

- read this press release for more

Suggested Articles

The public financing will enable Monopar to start a phase 3 trial of a prophylactic treatment for a side effect of chemoradiotherapy. 

The dispute centers on whether Asa Abeliovich used Alector’s confidential information in connection with his work for Prevail Therapeutics.

GSK poaches Merck KGaA's Martinez-Davis to helm pharma stateside; Bulto named Novartis U.S. pharma head; Allergan's Saunders set for huge parachute.